Follow-up after Ductal Carcinoma In Situ Treatment

Follow-up after ductal carcinoma in situ (DCIS) treatment is a matter of debates and a strategy has not yet been adopted. The current follow-up strategy is not distinguished from that of invasive breast cancers. Although in recent years DCIS is seen as a distinguished category of breast cancer, the...

Full description

Saved in:
Bibliographic Details
Published inChirurgia (Bucharest, Romania : 1990) Vol. 116; no. 5 Suppl; pp. S143 - S146
Main Authors Gica, Nicolae, Mustata, Laura Mihaela, Peltecu, Gheorghe, Panaitescu, Anca Maria
Format Journal Article
LanguageEnglish
Published Romania 01.12.2021
Subjects
Breast Neoplasms - therapy
Carcinoma in Situ
Carcinoma, Ductal, Breast
Carcinoma, Intraductal, Noninfiltrating - surgery
Female
Follow-Up Studies
Humans
Treatment Outcome
follow-up
treatment
ductalcarcinomainsitu
Online AccessGet full text

Cover

More Information
Summary:Follow-up after ductal carcinoma in situ (DCIS) treatment is a matter of debates and a strategy has not yet been adopted. The current follow-up strategy is not distinguished from that of invasive breast cancers. Although in recent years DCIS is seen as a distinguished category of breast cancer, the follow-up strategy does not reflect this new paradigm. It continues to use the same strategy like in invasive breast cancer and practices differ widely worldwide or even in the same country. A consensus is needed to keep safety of patients and save costs without compromising the outcome.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1221-9118
DOI:10.21614/chirurgia.116.5.Suppl.S143